Navigation Links
Rensselaer Professor Ryan Gilbert receives NSF CAREER award
Date:1/31/2012

Troy, N.Y. Ryan Gilbert, assistant professor in the Department of Biomedical Engineering at Rensselaer Polytechnic Institute, has won a prestigious Faculty Early Career Development Award (CAREER) from the National Science Foundation (NSF).

Gilbert will use the projected five-year, $500,000 award to develop new biomaterials for the treatment of spinal cord injuries. The CAREER Award is given to faculty members at the beginning of their academic careers and is one of NSF's most competitive awards, placing emphasis on high-quality research and novel education initiatives.

"We congratulate Dr. Gilbert for being selected to receive an NSF CAREER Award to support his leading-edge biomaterials research," said David Rosowsky, dean of the School of Engineering at Rensselaer. "The CAREER Award is one of the highest honors a young faculty member can receive, and Ryan is certainly deserving of this national recognition."

With his CAREER project, titled "Study of Astrocyte Migration and Reactivity Using Novel Biomaterial Platforms," Gilbert seeks to innovate a solution to the known problem of astrocyte reactivity. Individuals who suffer spinal cord injuries often lose body function below the injury site, which can lead to lifelong paralysis. Currently, there are no federally approved biological or drug-based treatments to restore this lost functionality, Gilbert said.

Gilbert's goal is to develop new biomaterials to reduce or eliminate the reactivity of astrocytes, glial cells found in the scar tissues of the spinal cord that are known to inhibit nerve regeneration. Additionally, Gilbert and his research team will develop polymer spheres that can travel through glial cells and scar tissue in order to deliver therapies to coax axons into the injury site. By delivering these therapies directly to the injury site and weakening the inhibitory nature of astrocytes, these new materials could aid the regeneration of nerve axons, he said. This research holds the promise of informing a new framework for developing novel strategies and treatments for spinal cord injury.

This research will be conducted in the world-class Center for Biotechnology and Interdisciplinary Studies (CBIS) at Rensselaer.

Along with educating undergraduates and graduate students in the areas of spinal cord injury research, advanced microscopy, and biomaterial fabrication, Gilbert's research program supports educational outreach initiatives to engage elementary, junior high school, and high school students about these important topics.

Gilbert joined the Rensselaer faculty in 2010, after serving as an assistant professor of biomedical engineering at Michigan Technological University (MTU). In 2008, he was inducted into MTU's Academy of Teaching Excellence. At Rensselaer, Gilbert currently advises four graduate students and five undergraduate students.

Gilbert received his bachelor's degree in chemical engineering from the University of Michigan, Ann Arbor, and his doctoral degree in biomedical engineering from Case Western Reserve University.


'/>"/>
Contact: Michael Mullaney
mullam@rpi.edu
518-276-6161
Rensselaer Polytechnic Institute
Source:Eurekalert  

Related biology news :

1. Trustee makes donation to start new solar energy research center at Rensselaer
2. Rensselaer receives more than $2 million from New York State to fund stem cell research
3. Rensselaer leads effort to replace 1 of the most widely used drugs in American hospitals
4. Rensselaer researchers to send bacteria into orbit aboard space shuttle Atlantis
5. Rensselaer Polytechnic Institute wins $2.45 million grant to support stem cell research
6. Rensselaer Polytechnic Institute professor Patrick Underhill receives NSF CAREER award
7. Rensselaer Polytechnic Institute professor Peter M. Tessier named Pew Scholar
8. Left or right? Early clues to soccer penalty kicks revealed at Rensselaer Polytechnic Institute
9. Rensselaer professor uncovers mysterious workings of cholera bacteria
10. Purifying proteins: Rensselaer researchers use NMR to improve drug development
11. Rensselaer professors Dordick and Interrante named ACS Fellows
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Rensselaer Professor Ryan Gilbert receives NSF CAREER award
(Date:5/20/2016)... -- VoiceIt is excited to announce its new marketing ... working together, VoiceIt and VoicePass will offer an ... slightly different approaches to voice biometrics, collaboration between ... Both companies ... "This marketing and technology partnership allows VoiceIt ...
(Date:4/28/2016)... India , April 28, 2016 ... Infosys (NYSE: INFY ), and Samsung SDS, a ... that will provide end customers with a more secure, ... services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) , ... services, but it also plays a fundamental part in enabling ...
(Date:4/15/2016)... , April 15, 2016  A new ... make more accurate underwriting decisions in a fraction ... timely, competitively priced and high-value life insurance policies ... screenings. With Force Diagnostics, rapid testing ... lifestyle data readings (blood pressure, weight, pulse, BMI, ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... ... 2016 , ... Parallel 6 , the leading software as a service ... Virtual Patient Encounter CONSULT module which enables both audio and video telemedicine communication ... , Using the CONSULT module, patients and physicians can schedule a face to face ...
(Date:6/27/2016)... , June 27, 2016   Ginkgo Bioworks , ... industrial engineering, was today awarded as one of ... of the world,s most innovative companies. Ginkgo Bioworks ... for the real world in the nutrition, health ... work directly with customers including Fortune 500 companies ...
(Date:6/24/2016)... ... June 24, 2016 , ... Researchers at the Universita Politecnica ... in people with peritoneal or pleural mesothelioma. Their findings are the subject of a ... , Diagnostic biomarkers are signposts in the blood, lung fluid or tissue of ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
Breaking Biology Technology: